As metastatic melanoma remains an extremely challenging cancer to treat, we suggest the role of α-MSH in melanoma progression merits further investigation as it may hold clues to the metastatic success of the tumour and may offer new approaches to developing therapies to reduce metastatic spread or enhance the ability of these cells to be detected by the immune system. This evidence concerns the gene STAMBP and metastatic melanoma.